Utility of mobile phone app-assisted screening for heart failure and heart stress in primary care
Abstract Background As heart failure (HF) still has a similar prognosis to some of the most common cancers, a timely diagnosis of HF is of paramount importance. We sought to determine whether a mobile phone app can facilitate screening for HF in primary care. Material and methods The national echoca...
Gespeichert in:
Veröffentlicht in: | European heart journal 2024-10, Vol.45 (Supplement_1) |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | Supplement_1 |
container_start_page | |
container_title | European heart journal |
container_volume | 45 |
creator | Trifunovic-Zamaklar, D Mladenovic, Z Stefanovic, M Tadic, S Apostolovic, S Maric Kocijancic, J Vranic, I Petrovic, O Milic, G Milovancev, A Filipovic, T Popovic, M Paunovic, I Neskovic, A N Stankovic, I |
description | Abstract
Background
As heart failure (HF) still has a similar prognosis to some of the most common cancers, a timely diagnosis of HF is of paramount importance. We sought to determine whether a mobile phone app can facilitate screening for HF in primary care.
Material and methods
The national echocardiographic society conducted a multicenter screening programme for HF in which general practitioners from 13 primary care centres used a mobile phone app to decide whether patients without a prior HF diagnosis should be referred to one of the 6 university hospitals for transthoracic echocardiography (TTE) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) testing. The app would recommend further testing (TTE and NT-proBNP) to patients with symptoms potentially associated with HF, atrial fibrillation, pathologic electrocardiogram (ECG), previous myocardial infarction or exposure to cardiotoxic cancer therapies, or at least two other risk factors listed in Figure (left panel). Patients with signs of HF were not eligible for the programme. The algorithms proposed in the 2021 ESC guidelines were used to diagnose HF across the entire spectrum of left ventricular ejection fraction (EF).
Results
Of the 930 screened outpatients (mean age 66±11 years, age range 21-91 years, 61% female), 318 symptomatic patients (34.2%) were diagnosed with new HF (Figure). HF with preserved (HFpEF) was diagnosed more frequently than HF with mildy reduced (HFmrEF) and reduced EF (HFrEF). Heart stress, defined as elevated plasma NT-proBNP in asymptomatic individuals with risk factors irrespective of the presence or absence of structural heart disease or cardiac dysfunction, was found in 22.3% (Figure, right panel). In multivariate regression analysis, advanced age, atrial fibrillation, pathological ECG, long-standing history of arterial hypertension and chronic kidney disease were independently associated with HF, while other risk factors were not (Figure, middle panel).
Conclusions
Screening in primary care based on symptoms and risk factors, facilitated by a mobile phone app, resulted in a new HF diagnosis in approximately one third of screened patients, with the majority of them having HFpEF. Recalibration of the referral criteria might further improve the performance of the app for screening purposes. |
doi_str_mv | 10.1093/eurheartj/ehae666.950 |
format | Article |
fullrecord | <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_eurheartj_ehae666_950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/eurheartj/ehae666.950</oup_id><sourcerecordid>10.1093/eurheartj/ehae666.950</sourcerecordid><originalsourceid>FETCH-LOGICAL-c870-6a2d9e9451f9eb9d863b40649b5449f887b0216ca4d3bb94509681ba74831f473</originalsourceid><addsrcrecordid>eNqNkMtqwzAQRUVpoWnaTyjoB5yMbGksLUvoCwLdpNCdkexRo-DYRnIW-fu6rem6q4HhnjvDYexewEqAKdZ0inuycTysaW8JEVdGwQVbCJXnmUGpLtkChFEZov64ZjcpHQBAo8AFs-9jaMN45r3nx96Flviw7zvidhgym1JIIzU81ZGoC90n933kP8e4t6E9xSnYNfMmjZFS4qHjQwxHG8-8tpFu2ZW3baK7eS7Z7ulxt3nJtm_Pr5uHbVbrEjK0eWPISCW8IWcajYWTgNI4JaXxWpcOcoG1lU3h3JQDg1o4W0pdCC_LYsnUb20d-5Qi-Wp-ohJQfWuq_jRVs6Zq0jRx8Mv1p-GfyBexYHFG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Utility of mobile phone app-assisted screening for heart failure and heart stress in primary care</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Trifunovic-Zamaklar, D ; Mladenovic, Z ; Stefanovic, M ; Tadic, S ; Apostolovic, S ; Maric Kocijancic, J ; Vranic, I ; Petrovic, O ; Milic, G ; Milovancev, A ; Filipovic, T ; Popovic, M ; Paunovic, I ; Neskovic, A N ; Stankovic, I</creator><creatorcontrib>Trifunovic-Zamaklar, D ; Mladenovic, Z ; Stefanovic, M ; Tadic, S ; Apostolovic, S ; Maric Kocijancic, J ; Vranic, I ; Petrovic, O ; Milic, G ; Milovancev, A ; Filipovic, T ; Popovic, M ; Paunovic, I ; Neskovic, A N ; Stankovic, I</creatorcontrib><description>Abstract
Background
As heart failure (HF) still has a similar prognosis to some of the most common cancers, a timely diagnosis of HF is of paramount importance. We sought to determine whether a mobile phone app can facilitate screening for HF in primary care.
Material and methods
The national echocardiographic society conducted a multicenter screening programme for HF in which general practitioners from 13 primary care centres used a mobile phone app to decide whether patients without a prior HF diagnosis should be referred to one of the 6 university hospitals for transthoracic echocardiography (TTE) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) testing. The app would recommend further testing (TTE and NT-proBNP) to patients with symptoms potentially associated with HF, atrial fibrillation, pathologic electrocardiogram (ECG), previous myocardial infarction or exposure to cardiotoxic cancer therapies, or at least two other risk factors listed in Figure (left panel). Patients with signs of HF were not eligible for the programme. The algorithms proposed in the 2021 ESC guidelines were used to diagnose HF across the entire spectrum of left ventricular ejection fraction (EF).
Results
Of the 930 screened outpatients (mean age 66±11 years, age range 21-91 years, 61% female), 318 symptomatic patients (34.2%) were diagnosed with new HF (Figure). HF with preserved (HFpEF) was diagnosed more frequently than HF with mildy reduced (HFmrEF) and reduced EF (HFrEF). Heart stress, defined as elevated plasma NT-proBNP in asymptomatic individuals with risk factors irrespective of the presence or absence of structural heart disease or cardiac dysfunction, was found in 22.3% (Figure, right panel). In multivariate regression analysis, advanced age, atrial fibrillation, pathological ECG, long-standing history of arterial hypertension and chronic kidney disease were independently associated with HF, while other risk factors were not (Figure, middle panel).
Conclusions
Screening in primary care based on symptoms and risk factors, facilitated by a mobile phone app, resulted in a new HF diagnosis in approximately one third of screened patients, with the majority of them having HFpEF. Recalibration of the referral criteria might further improve the performance of the app for screening purposes.</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehae666.950</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><ispartof>European heart journal, 2024-10, Vol.45 (Supplement_1)</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Trifunovic-Zamaklar, D</creatorcontrib><creatorcontrib>Mladenovic, Z</creatorcontrib><creatorcontrib>Stefanovic, M</creatorcontrib><creatorcontrib>Tadic, S</creatorcontrib><creatorcontrib>Apostolovic, S</creatorcontrib><creatorcontrib>Maric Kocijancic, J</creatorcontrib><creatorcontrib>Vranic, I</creatorcontrib><creatorcontrib>Petrovic, O</creatorcontrib><creatorcontrib>Milic, G</creatorcontrib><creatorcontrib>Milovancev, A</creatorcontrib><creatorcontrib>Filipovic, T</creatorcontrib><creatorcontrib>Popovic, M</creatorcontrib><creatorcontrib>Paunovic, I</creatorcontrib><creatorcontrib>Neskovic, A N</creatorcontrib><creatorcontrib>Stankovic, I</creatorcontrib><title>Utility of mobile phone app-assisted screening for heart failure and heart stress in primary care</title><title>European heart journal</title><description>Abstract
Background
As heart failure (HF) still has a similar prognosis to some of the most common cancers, a timely diagnosis of HF is of paramount importance. We sought to determine whether a mobile phone app can facilitate screening for HF in primary care.
Material and methods
The national echocardiographic society conducted a multicenter screening programme for HF in which general practitioners from 13 primary care centres used a mobile phone app to decide whether patients without a prior HF diagnosis should be referred to one of the 6 university hospitals for transthoracic echocardiography (TTE) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) testing. The app would recommend further testing (TTE and NT-proBNP) to patients with symptoms potentially associated with HF, atrial fibrillation, pathologic electrocardiogram (ECG), previous myocardial infarction or exposure to cardiotoxic cancer therapies, or at least two other risk factors listed in Figure (left panel). Patients with signs of HF were not eligible for the programme. The algorithms proposed in the 2021 ESC guidelines were used to diagnose HF across the entire spectrum of left ventricular ejection fraction (EF).
Results
Of the 930 screened outpatients (mean age 66±11 years, age range 21-91 years, 61% female), 318 symptomatic patients (34.2%) were diagnosed with new HF (Figure). HF with preserved (HFpEF) was diagnosed more frequently than HF with mildy reduced (HFmrEF) and reduced EF (HFrEF). Heart stress, defined as elevated plasma NT-proBNP in asymptomatic individuals with risk factors irrespective of the presence or absence of structural heart disease or cardiac dysfunction, was found in 22.3% (Figure, right panel). In multivariate regression analysis, advanced age, atrial fibrillation, pathological ECG, long-standing history of arterial hypertension and chronic kidney disease were independently associated with HF, while other risk factors were not (Figure, middle panel).
Conclusions
Screening in primary care based on symptoms and risk factors, facilitated by a mobile phone app, resulted in a new HF diagnosis in approximately one third of screened patients, with the majority of them having HFpEF. Recalibration of the referral criteria might further improve the performance of the app for screening purposes.</description><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqNkMtqwzAQRUVpoWnaTyjoB5yMbGksLUvoCwLdpNCdkexRo-DYRnIW-fu6rem6q4HhnjvDYexewEqAKdZ0inuycTysaW8JEVdGwQVbCJXnmUGpLtkChFEZov64ZjcpHQBAo8AFs-9jaMN45r3nx96Flviw7zvidhgym1JIIzU81ZGoC90n933kP8e4t6E9xSnYNfMmjZFS4qHjQwxHG8-8tpFu2ZW3baK7eS7Z7ulxt3nJtm_Pr5uHbVbrEjK0eWPISCW8IWcajYWTgNI4JaXxWpcOcoG1lU3h3JQDg1o4W0pdCC_LYsnUb20d-5Qi-Wp-ohJQfWuq_jRVs6Zq0jRx8Mv1p-GfyBexYHFG</recordid><startdate>20241028</startdate><enddate>20241028</enddate><creator>Trifunovic-Zamaklar, D</creator><creator>Mladenovic, Z</creator><creator>Stefanovic, M</creator><creator>Tadic, S</creator><creator>Apostolovic, S</creator><creator>Maric Kocijancic, J</creator><creator>Vranic, I</creator><creator>Petrovic, O</creator><creator>Milic, G</creator><creator>Milovancev, A</creator><creator>Filipovic, T</creator><creator>Popovic, M</creator><creator>Paunovic, I</creator><creator>Neskovic, A N</creator><creator>Stankovic, I</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20241028</creationdate><title>Utility of mobile phone app-assisted screening for heart failure and heart stress in primary care</title><author>Trifunovic-Zamaklar, D ; Mladenovic, Z ; Stefanovic, M ; Tadic, S ; Apostolovic, S ; Maric Kocijancic, J ; Vranic, I ; Petrovic, O ; Milic, G ; Milovancev, A ; Filipovic, T ; Popovic, M ; Paunovic, I ; Neskovic, A N ; Stankovic, I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c870-6a2d9e9451f9eb9d863b40649b5449f887b0216ca4d3bb94509681ba74831f473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trifunovic-Zamaklar, D</creatorcontrib><creatorcontrib>Mladenovic, Z</creatorcontrib><creatorcontrib>Stefanovic, M</creatorcontrib><creatorcontrib>Tadic, S</creatorcontrib><creatorcontrib>Apostolovic, S</creatorcontrib><creatorcontrib>Maric Kocijancic, J</creatorcontrib><creatorcontrib>Vranic, I</creatorcontrib><creatorcontrib>Petrovic, O</creatorcontrib><creatorcontrib>Milic, G</creatorcontrib><creatorcontrib>Milovancev, A</creatorcontrib><creatorcontrib>Filipovic, T</creatorcontrib><creatorcontrib>Popovic, M</creatorcontrib><creatorcontrib>Paunovic, I</creatorcontrib><creatorcontrib>Neskovic, A N</creatorcontrib><creatorcontrib>Stankovic, I</creatorcontrib><collection>CrossRef</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trifunovic-Zamaklar, D</au><au>Mladenovic, Z</au><au>Stefanovic, M</au><au>Tadic, S</au><au>Apostolovic, S</au><au>Maric Kocijancic, J</au><au>Vranic, I</au><au>Petrovic, O</au><au>Milic, G</au><au>Milovancev, A</au><au>Filipovic, T</au><au>Popovic, M</au><au>Paunovic, I</au><au>Neskovic, A N</au><au>Stankovic, I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utility of mobile phone app-assisted screening for heart failure and heart stress in primary care</atitle><jtitle>European heart journal</jtitle><date>2024-10-28</date><risdate>2024</risdate><volume>45</volume><issue>Supplement_1</issue><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Abstract
Background
As heart failure (HF) still has a similar prognosis to some of the most common cancers, a timely diagnosis of HF is of paramount importance. We sought to determine whether a mobile phone app can facilitate screening for HF in primary care.
Material and methods
The national echocardiographic society conducted a multicenter screening programme for HF in which general practitioners from 13 primary care centres used a mobile phone app to decide whether patients without a prior HF diagnosis should be referred to one of the 6 university hospitals for transthoracic echocardiography (TTE) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) testing. The app would recommend further testing (TTE and NT-proBNP) to patients with symptoms potentially associated with HF, atrial fibrillation, pathologic electrocardiogram (ECG), previous myocardial infarction or exposure to cardiotoxic cancer therapies, or at least two other risk factors listed in Figure (left panel). Patients with signs of HF were not eligible for the programme. The algorithms proposed in the 2021 ESC guidelines were used to diagnose HF across the entire spectrum of left ventricular ejection fraction (EF).
Results
Of the 930 screened outpatients (mean age 66±11 years, age range 21-91 years, 61% female), 318 symptomatic patients (34.2%) were diagnosed with new HF (Figure). HF with preserved (HFpEF) was diagnosed more frequently than HF with mildy reduced (HFmrEF) and reduced EF (HFrEF). Heart stress, defined as elevated plasma NT-proBNP in asymptomatic individuals with risk factors irrespective of the presence or absence of structural heart disease or cardiac dysfunction, was found in 22.3% (Figure, right panel). In multivariate regression analysis, advanced age, atrial fibrillation, pathological ECG, long-standing history of arterial hypertension and chronic kidney disease were independently associated with HF, while other risk factors were not (Figure, middle panel).
Conclusions
Screening in primary care based on symptoms and risk factors, facilitated by a mobile phone app, resulted in a new HF diagnosis in approximately one third of screened patients, with the majority of them having HFpEF. Recalibration of the referral criteria might further improve the performance of the app for screening purposes.</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/eurheartj/ehae666.950</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0195-668X |
ispartof | European heart journal, 2024-10, Vol.45 (Supplement_1) |
issn | 0195-668X 1522-9645 |
language | eng |
recordid | cdi_crossref_primary_10_1093_eurheartj_ehae666_950 |
source | Oxford University Press Journals All Titles (1996-Current) |
title | Utility of mobile phone app-assisted screening for heart failure and heart stress in primary care |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A42%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utility%20of%20mobile%20phone%20app-assisted%20screening%20for%20heart%20failure%20and%20heart%20stress%20in%20primary%20care&rft.jtitle=European%20heart%20journal&rft.au=Trifunovic-Zamaklar,%20D&rft.date=2024-10-28&rft.volume=45&rft.issue=Supplement_1&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehae666.950&rft_dat=%3Coup_cross%3E10.1093/eurheartj/ehae666.950%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/eurheartj/ehae666.950&rfr_iscdi=true |